RTTNews | Dec 17, 2020 07:09AM EST

07:09 Thursday, December 17, 2020 (RTTNews.com) - Specialty pharmaceutical firm ANI Pharmaceuticals, Inc. (ANIP) announced Thursday that the U.S. Food and Drug Administration (FDA) approval and the launch of Aminocaproic Acid Tablets USP, 500mg.

The current annual U.S. market for this product is approximately $12.7 million, according to IQVIA/IMS Health. This important therapeutic is one of the pipeline generic products ANI acquired from Amerigen Pharmaceuticals, Ltd. earlier this year.

Aminocaproic Acid tablets are useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required.

Read the original article on RTTNews ( https://www.rttnews.com/3154591/ani-pharma-says-fda-approved-and-launched-aminocaproic-acid-tablets-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved